ProQR Therapeutics NV (NASDAQ:PRQR)
| 0.7499 Delayed Data As of Sep 30 |  -0.0116 / -1.54%Today’s Change | 0.53 Today|||52-Week Range 8.67 | -90.64% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -23.1M | -43.3M | -49.3M | -43.8M | |
| Depreciation | 124.2K | 1.4M | 1.2M | 1.1M | ||
| Total Other Cash Flow | -4.6M | 2.5M | 8.5M | 7.5M | ||
| Funds From Operations | -27.6M | -39.4M | -39.6M | -35.1M | ||
| Funds From/For Other Operating Expenses | -706.4K | -1.6M | -185.0K | -1.5M | ||
| Net Cash Flow - Operating Activities | -26.9M | -37.9M | -39.4M | -33.6M | ||
| Investing | Capital Expenditures | -1.4M | -2.8M | -136.5K | -368.1K | |
| Net Cash Flow Investing | -1.5M | -2.8M | -136.5K | -368.1K | ||
| Financing | Short Term Borrowings | -- | 0.00 | -- | 0.00 | -- |
| Long Term Borrowings | 1.8M | 409.3K | 1.1M | 0.00 | ||
| Long Term Debt Reduction | -37.7K | -16.6K | 0.00 | 0.00 | ||
| Net Proceeds Stock Sale | 15.5K | 2.2K | 29.0M | 100.4M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 1.8M | 394.9K | 30.0M | 102.0M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | 6.7M | 816.4K | -3.0M | -201.7K | |
| Net Change In Cash | -26.5M | -40.3M | -9.5M | 68.0M | ||
